Healthcare facilities across the United States are revising HVAC procurement timelines and sourcing strategies as a severe supply shortage of R-454B - the low-GWP refrigerant mandated by the EPA under the American Innovation and Manufacturing (AIM) Act - disrupts capital equipment planning and threatens system continuity. The crunch, driven by cylinder shortages, manufacturing bottlenecks, and surging demand, is forcing facility managers and engineering teams to pivot toward alternative compliant refrigerants and phased retrofit programs to maintain operations and regulatory standing.
Background
Under the EPA's Technology Transitions Rule, enacted pursuant to the AIM Act of 2020, all newly manufactured residential and light commercial HVAC systems must use refrigerants with a GWP of 700 or lower, effective January 1, 2025. This mandate effectively ended production of new R-410A equipment and designated R-454B - a blend of R-32 and R-1234yf with a GWP of 466, approximately 78% lower than R-410A's 2,088 - as the primary successor for most new comfort cooling systems. R-32 (GWP: 675) serves as an equally compliant alternative, already widely used by manufacturers including Daikin, Goodman, and Amana.
The regulatory shift set a firm compliance horizon that healthcare facilities - which operate HVAC systems continuously and cannot tolerate unplanned downtime - must navigate carefully. Starting January 1, 2026, the EPA's HFC Leak Repair and Management Rule additionally imposes mandatory leak detection and repair requirements on owners or operators of refrigerant-containing appliances with a charge of 15 pounds or greater, according to the Federal Register. This lowers the previous 50-pound threshold by 70%, bringing a large share of hospital rooftop units and air-handling equipment under federal oversight for the first time.
Details
The R-454B supply disruption has been severe. In April 2025, Honeywell announced it could no longer keep pace with "unprecedented demand" for R-454B and applied a 42% price surcharge, according to ACHR News. Cylinder prices for a 20-lb unit reached $700-$2,000 in 2025, compared with $344.94 in 2021, according to Honeywell and Chemours pricing data. The shortage traces to multiple converging factors: a lack of DOT-certified, A2L-rated cylinders, with Worthington Enterprises, a leading cylinder manufacturer, struggling to scale production fast enough to meet demand according to ACHR News; and manufacturing bottlenecks at blending facilities still retooling to produce R-454B at scale when the 2025 demand spike hit.
ACCA's polling showed that 48% of its contractor members were feeling the effects of the refrigerant transition, according to ACCA President and CEO Barton James. Contractors reported procurement delays of four to ten weeks during peak cooling season, with some distributors rationing R-454B to critical repairs only.
For healthcare procurement teams, the implications extend beyond price. Most legacy R-410A systems are not designed for refrigerant conversion - differences in lubricant requirements, safety classifications, and component compatibility generally require full equipment replacement rather than drop-in substitution, according to industry guidance from Kele and Carrier. Mixing refrigerants voids manufacturer warranties, fails UL standards, and may cause compressor damage, according to Carrier's technical guidance published by ACCA.
In response, facility teams are increasingly turning to R-32 as a near-term alternative. R-32 meets the EPA's GWP threshold and, unlike R-454B, benefits from a mature global supply chain. R-32 cylinder prices range from approximately $218-$350 per 20-lb unit, significantly below R-454B's 2025 peak pricing, according to industry data. Arkema has stated that R-32 is "readily available" with "few reported problems in accessing it," while the infrastructure for R-454B continues to develop.
The EPA formally acknowledged the supply disruption. In a September 2025 fact sheet, the EPA stated that "spring and summer of 2025 brought significant challenges to the residential market due to supply chain issues resulting in shortages, price spikes, and stockpiling of R-454B" and proposed removing the installation deadline for residential and light commercial systems to allow sell-through of pre-2025 R-410A inventory. On October 3, 2025, the EPA published a proposed rule in the Federal Register proposing to remove the installation compliance date for residential and light commercial air conditioning and heat pump systems where all components were manufactured or imported before January 1, 2025.
HARDI, the distributor trade association, reported easing conditions by mid-autumn. According to HARDI's director of government affairs, Alex Ayers, speaking in October 2025: "If you were to be really specific, I would definitely say the crisis is over", with distributors reporting improved R-454B availability beginning in late August and September as the cooling season slowed and supply chains caught up.
Outlook
Healthcare HVAC managers should not interpret the partial supply stabilization as grounds to delay capital planning. Facilities that delay a 2025-2028 retrofit decision window face higher equipment demand, compressed timelines, and the steepest refrigerant cost increases projected under the AIM Act phasedown schedule heading into 2029, according to analysis by OxMaint. The EPA's HFC Leak Management Rule, effective January 1, 2026, requires facilities to audit refrigerant inventories, implement leak detection on newly covered systems, and maintain comprehensive service documentation for a minimum of three years. Procurement strategies that secure forward supply agreements for R-32 or early equipment orders for R-454B-rated systems - combined with phased retrofit scheduling tied to planned maintenance windows - represent the most defensible path for facilities balancing compliance obligations, operational continuity, and capital budget cycles.
